Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5199708
Max Phase: Preclinical
Molecular Formula: C33H49NO9
Molecular Weight: 603.75
Associated Items:
ID: ALA5199708
Max Phase: Preclinical
Molecular Formula: C33H49NO9
Molecular Weight: 603.75
Associated Items:
Canonical SMILES: CC(/C=C/[C@H]1O[C@H](CC(=O)OC2CC2)C[C@@]2(CO2)[C@@H]1O)=C\C[C@@H]1O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(=O)C(C)C)C[C@@H]1C
Standard InChI: InChI=1S/C33H49NO9/c1-19(2)32(38)40-22(5)9-14-29(35)34-26-15-21(4)27(41-23(26)6)12-7-20(3)8-13-28-31(37)33(18-39-33)17-25(42-28)16-30(36)43-24-10-11-24/h7-9,13-14,19,21-28,31,37H,10-12,15-18H2,1-6H3,(H,34,35)/b13-8+,14-9-,20-7+/t21-,22-,23+,25+,26+,27-,28+,31+,33+/m0/s1
Standard InChI Key: FVIISXRQJKQRGO-NFUAKRLWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 603.75 | Molecular Weight (Monoisotopic): 603.3407 | AlogP: 3.70 | #Rotatable Bonds: 12 |
Polar Surface Area: 132.92 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.92 | CX Basic pKa: | CX LogP: 3.43 | CX LogD: 3.43 |
Aromatic Rings: 0 | Heavy Atoms: 43 | QED Weighted: 0.15 | Np Likeness Score: 2.21 |
1. Ghosh AK, Mishevich JL, Jurica MS.. (2021) Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors., 84 (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100] |
Source(1):